Anhydroerythromycin A [CAS 23893-13-2]
Partner: MedChemexpress LLC
| CAS No: | 23893-13-2 |
| MW: | 715.91 |
| Formula: | C37H65NO12 |
| SMILES: | C[C@H]([C@H]1O)[C@@](O[C@@]1([C@H](OC2=O)CC)C)([C@@H](C3)C)O[C@]3([C@@H]([C@H]([C@@H]([C@H]2C)O[C@H](O[C@H]4C)C[C@](C)([C@H]4O)OC)C)O[C@H](O[C@@H]5C)[C@@H]([C@H](C5)N(C)C)O)C |
| Description: | Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed via degradation of erythromycin in acidic aqueous solutions in vitro as well as in vivo. Anhydroerythromycin A is active against S. aureus and B. cereus in vitro (MICs = 12.5 and 6.25 ?g/ml, respectively). Anhydroerythromycin A also inhibits steroid 6?-hydroxylase activity associated with the cytochrome P450 (CYP) isoform CYP3A in human liver microsomes. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
